126 related articles for article (PubMed ID: 20682302)
1. Antinociceptive effects of histamine H3 receptor antagonist in the preclinical models of pain in rats and the involvement of central noradrenergic systems.
Hsieh GC; Honore P; Pai M; Wensink EJ; Chandran P; Salyers AK; Wetter JM; Zhao C; Liu H; Decker MW; Esbenshade TA; Cowart MD; Brioni JD
Brain Res; 2010 Oct; 1354():74-84. PubMed ID: 20682302
[TBL] [Abstract][Full Text] [Related]
2. Antagonism of supraspinal histamine H3 receptors modulates spinal neuronal activity in neuropathic rats.
McGaraughty S; Chu KL; Cowart MD; Brioni JD
J Pharmacol Exp Ther; 2012 Oct; 343(1):13-20. PubMed ID: 22729221
[TBL] [Abstract][Full Text] [Related]
3. Novel histamine H3 receptor antagonists GSK189254 and GSK334429 are efficacious in surgically-induced and virally-induced rat models of neuropathic pain.
Medhurst SJ; Collins SD; Billinton A; Bingham S; Dalziel RG; Brass A; Roberts JC; Medhurst AD; Chessell IP
Pain; 2008 Aug; 138(1):61-69. PubMed ID: 18164820
[TBL] [Abstract][Full Text] [Related]
4. GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer's disease brain and improves cognitive performance in preclinical models.
Medhurst AD; Atkins AR; Beresford IJ; Brackenborough K; Briggs MA; Calver AR; Cilia J; Cluderay JE; Crook B; Davis JB; Davis RK; Davis RP; Dawson LA; Foley AG; Gartlon J; Gonzalez MI; Heslop T; Hirst WD; Jennings C; Jones DN; Lacroix LP; Martyn A; Ociepka S; Ray A; Regan CM; Roberts JC; Schogger J; Southam E; Stean TO; Trail BK; Upton N; Wadsworth G; Wald JA; White T; Witherington J; Woolley ML; Worby A; Wilson DM
J Pharmacol Exp Ther; 2007 Jun; 321(3):1032-45. PubMed ID: 17327487
[TBL] [Abstract][Full Text] [Related]
5. Regional differential effects of the novel histamine H3 receptor antagonist 6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-N-methyl-3-pyridinecarboxamide hydrochloride (GSK189254) on histamine release in the central nervous system of freely moving rats.
Giannoni P; Medhurst AD; Passani MB; Giovannini MG; Ballini C; Corte LD; Blandina P
J Pharmacol Exp Ther; 2010 Jan; 332(1):164-72. PubMed ID: 19815811
[TBL] [Abstract][Full Text] [Related]
6. Blockade of the brain histamine H3 receptor by JNJ-39220675: preclinical PET studies with [¹¹C]GSK189254 in anesthetized baboon.
Logan J; Carruthers NI; Letavic MA; Sands S; Jiang X; Shea C; Muench L; Xu Y; Carter P; King P; Fowler JS
Psychopharmacology (Berl); 2012 Oct; 223(4):447-55. PubMed ID: 22614669
[TBL] [Abstract][Full Text] [Related]
7. Endogenous opioid mechanisms partially mediate P2X3/P2X2/3-related antinociception in rat models of inflammatory and chemogenic pain but not neuropathic pain.
McGaraughty S; Honore P; Wismer CT; Mikusa J; Zhu CZ; McDonald HA; Bianchi B; Faltynek CR; Jarvis MF
Br J Pharmacol; 2005 Sep; 146(2):180-8. PubMed ID: 16041397
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of A-960656, a histamine H₃ receptor antagonist with efficacy in animal models of osteoarthritis and neuropathic pain.
Cowart M; Hsieh G; Black LA; Zhan C; Gomez EJ; Pai M; Strakhova M; Manelli A; Carr T; Wetter J; Lee A; Diaz G; Garrison T; Brioni JD
Eur J Pharmacol; 2012 Jun; 684(1-3):87-94. PubMed ID: 22504024
[TBL] [Abstract][Full Text] [Related]
9. H3 receptor antagonism enhances NCAM PSA-mediated plasticity and improves memory consolidation in odor discrimination and delayed match-to-position paradigms.
Foley AG; Prendergast A; Barry C; Scully D; Upton N; Medhurst AD; Regan CM
Neuropsychopharmacology; 2009 Nov; 34(12):2585-600. PubMed ID: 19657331
[TBL] [Abstract][Full Text] [Related]
10. Activation of peripheral and spinal histamine H3 receptors inhibits formalin-induced inflammation and nociception, respectively.
Cannon KE; Leurs R; Hough LB
Pharmacol Biochem Behav; 2007 Nov; 88(1):122-9. PubMed ID: 17719621
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of acute and repeat dosing with the H3 antagonist GSK189254 on the sleep-wake cycle and narcoleptic episodes in Ox-/- mice.
Guo RX; Anaclet C; Roberts JC; Parmentier R; Zhang M; Guidon G; Buda C; Sastre JP; Feng JQ; Franco P; Brown SH; Upton N; Medhurst AD; Lin JS
Br J Pharmacol; 2009 May; 157(1):104-17. PubMed ID: 19413575
[TBL] [Abstract][Full Text] [Related]
12. Antinociceptive and antihyperalgesic effects of tapentadol in animal models of inflammatory pain.
Schiene K; De Vry J; Tzschentke TM
J Pharmacol Exp Ther; 2011 Nov; 339(2):537-44. PubMed ID: 21816956
[TBL] [Abstract][Full Text] [Related]
13. 11C-GSK189254: a selective radioligand for in vivo central nervous system imaging of histamine H3 receptors by PET.
Plisson C; Gunn RN; Cunningham VJ; Bender D; Salinas CA; Medhurst AD; Roberts JC; Laruelle M; Gee AD
J Nucl Med; 2009 Dec; 50(12):2064-72. PubMed ID: 19910432
[TBL] [Abstract][Full Text] [Related]
14. Differential contribution of opioid and noradrenergic mechanisms of tapentadol in rat models of nociceptive and neuropathic pain.
Schröder W; Vry JD; Tzschentke TM; Jahnel U; Christoph T
Eur J Pain; 2010 Sep; 14(8):814-21. PubMed ID: 20541444
[TBL] [Abstract][Full Text] [Related]
15. Structurally novel histamine H3 receptor antagonists GSK207040 and GSK334429 improve scopolamine-induced memory impairment and capsaicin-induced secondary allodynia in rats.
Medhurst AD; Briggs MA; Bruton G; Calver AR; Chessell I; Crook B; Davis JB; Davis RP; Foley AG; Heslop T; Hirst WD; Medhurst SJ; Ociepka S; Ray A; Regan CM; Sargent B; Schogger J; Stean TO; Trail BK; Upton N; White T; Orlek B; Wilson DM
Biochem Pharmacol; 2007 Apr; 73(8):1182-94. PubMed ID: 17276409
[TBL] [Abstract][Full Text] [Related]
16. In vivo receptor occupancy assay of histamine H₃ receptor antagonist in rats using non-radiolabeled tracer.
Nirogi R; Kandikere V; Bhyrapuneni G; Muddana N; Saralaya R; Ponnamaneni RK; Manoharan AK
J Pharmacol Toxicol Methods; 2012; 65(3):115-21. PubMed ID: 22487318
[TBL] [Abstract][Full Text] [Related]
17. Caffeine antinociception in the rat hot-plate and formalin tests and locomotor stimulation: involvement of noradrenergic mechanisms.
Sawynok J; Reid AR; Doak GJ
Pain; 1995 May; 61(2):203-213. PubMed ID: 7659430
[TBL] [Abstract][Full Text] [Related]
18. The Histamine H
Borgonetti V; Galeotti N
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430790
[TBL] [Abstract][Full Text] [Related]
19. Activation of spinal histamine H3 receptors inhibits mechanical nociception.
Cannon KE; Nalwalk JW; Stadel R; Ge P; Lawson D; Silos-Santiago I; Hough LB
Eur J Pharmacol; 2003 Jun; 470(3):139-47. PubMed ID: 12798951
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of 11C-GSK189254 as a novel radioligand for the H3 receptor in humans using PET.
Ashworth S; Rabiner EA; Gunn RN; Plisson C; Wilson AA; Comley RA; Lai RY; Gee AD; Laruelle M; Cunningham VJ
J Nucl Med; 2010 Jul; 51(7):1021-9. PubMed ID: 20554726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
